These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 36071579

  • 1. Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia.
    Di Modica SM, Tanzi E, Olivari V, Lidonnici MR, Pettinato M, Pagani A, Tiboni F, Furiosi V, Silvestri L, Ferrari G, Rivella S, Nai A.
    Am J Hematol; 2022 Oct; 97(10):1324-1336. PubMed ID: 36071579
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.
    Tanzi E, Di Modica SM, Bordini J, Olivari V, Pagani A, Furiosi V, Silvestri L, Campanella A, Nai A.
    Am J Hematol; 2024 Jul; 99(7):1313-1325. PubMed ID: 38629683
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O, Adamsky K, Amariglio N, Rachmilewitz E, Breda L, Rivella S, Rechavi G.
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
    Olivari V, Di Modica SM, Lidonnici MR, Aghajan M, Cordero-Sanchez C, Tanzi E, Pettinato M, Pagani A, Tiboni F, Silvestri L, Guo S, Ferrari G, Nai A.
    Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
    [Abstract] [Full Text] [Related]

  • 9. Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes.
    Dissanayake R, Samarasinghe N, Waidyanatha S, Pathirana S, Neththikumara N, Dissanayake VHW, Wetthasinghe K, Gooneratne L, Wickramasinghe P.
    BMC Pediatr; 2022 Jun 15; 22(1):344. PubMed ID: 35705926
    [Abstract] [Full Text] [Related]

  • 10. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.
    De Franceschi L, Daraio F, Filippini A, Carturan S, Muchitsch EM, Roetto A, Camaschella C.
    Haematologica; 2006 Oct 15; 91(10):1336-42. PubMed ID: 17018382
    [Abstract] [Full Text] [Related]

  • 11. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
    Schmidt PJ, Toudjarska I, Sendamarai AK, Racie T, Milstein S, Bettencourt BR, Hettinger J, Bumcrot D, Fleming MD.
    Blood; 2013 Feb 14; 121(7):1200-8. PubMed ID: 23223430
    [Abstract] [Full Text] [Related]

  • 12. Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.
    Wortham AM, Goldman DC, Chen J, Fleming WH, Zhang AS, Enns CA.
    J Biol Chem; 2020 Mar 20; 295(12):3906-3917. PubMed ID: 32054685
    [Abstract] [Full Text] [Related]

  • 13. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia.
    Suragani RN, Cawley SM, Li R, Wallner S, Alexander MJ, Mulivor AW, Gardenghi S, Rivella S, Grinberg AV, Pearsall RS, Kumar R.
    Blood; 2014 Jun 19; 123(25):3864-72. PubMed ID: 24795345
    [Abstract] [Full Text] [Related]

  • 14. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
    Rivella S, May C, Chadburn A, Rivière I, Sadelain M.
    Blood; 2003 Apr 15; 101(8):2932-9. PubMed ID: 12480689
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.
    Nai A, Pellegrino RM, Rausa M, Pagani A, Boero M, Silvestri L, Saglio G, Roetto A, Camaschella C.
    Haematologica; 2014 Jun 15; 99(6):1016-21. PubMed ID: 24658816
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E.
    Haematologica; 2007 May 15; 92(5):583-8. PubMed ID: 17488680
    [Abstract] [Full Text] [Related]

  • 19. Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia.
    Rishi G, Secondes ES, Wallace DF, Subramaniam VN.
    Am J Hematol; 2016 Aug 15; 91(8):812-8. PubMed ID: 27169626
    [Abstract] [Full Text] [Related]

  • 20. Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous B1/B2 globin gene deletion) mice.
    Gelderman MP, Baek JH, Yalamanoglu A, Puglia M, Vallelian F, Burla B, Vostal J, Schaer DJ, Buehler PW.
    Haematologica; 2015 May 15; 100(5):611-22. PubMed ID: 25616571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.